303 related articles for article (PubMed ID: 36399325)
21. Cancer-associated fibroblasts in pancreatic cancer: new subtypes, new markers, new targets.
Menezes S; Okail MH; Jalil SMA; Kocher HM; Cameron AJM
J Pathol; 2022 Jul; 257(4):526-544. PubMed ID: 35533046
[TBL] [Abstract][Full Text] [Related]
22. Single-Cell Transcriptomic Analysis of Tumor-Derived Fibroblasts and Normal Tissue-Resident Fibroblasts Reveals Fibroblast Heterogeneity in Breast Cancer.
Sebastian A; Hum NR; Martin KA; Gilmore SF; Peran I; Byers SW; Wheeler EK; Coleman MA; Loots GG
Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32455670
[TBL] [Abstract][Full Text] [Related]
23. Targeting cancer-associated fibroblasts: Challenges, opportunities and future directions.
Jenkins BH; Buckingham JF; Hanley CJ; Thomas GJ
Pharmacol Ther; 2022 Dec; 240():108231. PubMed ID: 35718294
[TBL] [Abstract][Full Text] [Related]
24. Cancer associated fibroblasts sculpt tumour microenvironment by recruiting monocytes and inducing immunosuppressive PD-1
Gok Yavuz B; Gunaydin G; Gedik ME; Kosemehmetoglu K; Karakoc D; Ozgur F; Guc D
Sci Rep; 2019 Feb; 9(1):3172. PubMed ID: 30816272
[TBL] [Abstract][Full Text] [Related]
25. The advent of immune stimulating CAFs in cancer.
Tsoumakidou M
Nat Rev Cancer; 2023 Apr; 23(4):258-269. PubMed ID: 36807417
[TBL] [Abstract][Full Text] [Related]
26. Cancer-associated fibroblasts: Is it a key to an intricate lock of tumorigenesis?
Aden D; Zaheer S; Ahluwalia H; Ranga S
Cell Biol Int; 2023 May; 47(5):859-893. PubMed ID: 36871165
[TBL] [Abstract][Full Text] [Related]
27. What is new in cancer-associated fibroblast biomarkers?
Zhao Z; Li T; Yuan Y; Zhu Y
Cell Commun Signal; 2023 May; 21(1):96. PubMed ID: 37143134
[TBL] [Abstract][Full Text] [Related]
28. Recent advances in understanding cancer-associated fibroblasts in pancreatic cancer.
Huang H; Brekken RA
Am J Physiol Cell Physiol; 2020 Aug; 319(2):C233-C243. PubMed ID: 32432930
[TBL] [Abstract][Full Text] [Related]
29. Cancer associated fibroblasts: is the force the path to the dark side?
Barbazán J; Matic Vignjevic D
Curr Opin Cell Biol; 2019 Feb; 56():71-79. PubMed ID: 30308331
[TBL] [Abstract][Full Text] [Related]
30. Targeting CAFs to overcome anticancer therapeutic resistance.
Saw PE; Chen J; Song E
Trends Cancer; 2022 Jul; 8(7):527-555. PubMed ID: 35331673
[TBL] [Abstract][Full Text] [Related]
31. Architecture of Cancer-Associated Fibroblasts in Tumor Microenvironment: Mapping Their Origins, Heterogeneity, and Role in Cancer Therapy Resistance.
Dzobo K; Dandara C
OMICS; 2020 Jun; 24(6):314-339. PubMed ID: 32496970
[TBL] [Abstract][Full Text] [Related]
32. Comprehensive analyses of the cancer-associated fibroblast subtypes and their score system for prediction of outcomes and immunosuppressive microenvironment in prostate cancer.
Gao Z; Zhang N; An B; Li D; Fang Z; Xu D
Cancer Cell Int; 2024 Apr; 24(1):127. PubMed ID: 38580966
[TBL] [Abstract][Full Text] [Related]
33. Cancer-associated fibroblasts that restrain cancer progression: Hypotheses and perspectives.
Miyai Y; Esaki N; Takahashi M; Enomoto A
Cancer Sci; 2020 Apr; 111(4):1047-1057. PubMed ID: 32060987
[TBL] [Abstract][Full Text] [Related]
34. [The Role of Cancer-Associated Fibroblasts in Modulating Tumor Immunity in Colorectal Cancer].
Kasashima H; Fukui Y; Kitayama K; Miki Y; Yoshii M; Fukuoka T; Tamura T; Shibutani M; Toyokawa T; Ree S; Tanaka H; Yashiro M; Maeda K
Gan To Kagaku Ryoho; 2023 Sep; 50(9):958-959. PubMed ID: 37800287
[TBL] [Abstract][Full Text] [Related]
35. The interplay between cancer associated fibroblasts and immune cells in the context of radiation therapy.
Piper M; Mueller AC; Karam SD
Mol Carcinog; 2020 Jul; 59(7):754-765. PubMed ID: 32363633
[TBL] [Abstract][Full Text] [Related]
36. The Origin, Differentiation, and Functions of Cancer-Associated Fibroblasts in Gastrointestinal Cancer.
Huang J; Tsang WY; Li ZH; Guan XY
Cell Mol Gastroenterol Hepatol; 2023; 16(4):503-511. PubMed ID: 37451403
[TBL] [Abstract][Full Text] [Related]
37. Fibroblast diversity and plasticity in the tumor microenvironment: roles in immunity and relevant therapies.
Xu Y; Li W; Lin S; Liu B; Wu P; Li L
Cell Commun Signal; 2023 Sep; 21(1):234. PubMed ID: 37723510
[TBL] [Abstract][Full Text] [Related]
38. Differential induction of T-cell tolerance by tumour fibroblast subsets.
Chua ZM; Tajebe F; Abuwarwar M; Fletcher AL
Curr Opin Immunol; 2024 Feb; 86():102410. PubMed ID: 38237251
[TBL] [Abstract][Full Text] [Related]
39. Single-cell RNA sequencing to explore cancer-associated fibroblasts heterogeneity: "Single" vision for "heterogeneous" environment.
Zhang X; Zhu R; Yu D; Wang J; Yan Y; Xu K
Cell Prolif; 2024 May; 57(5):e13592. PubMed ID: 38158643
[TBL] [Abstract][Full Text] [Related]
40. Cancer-associated fibroblasts: Versatile mediators in remodeling the tumor microenvironment.
Zhang Q; Wang Y; Liu F
Cell Signal; 2023 Mar; 103():110567. PubMed ID: 36538999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
